Saturday 17 October 2026
Export QSI’s income statement to Excel — free account
Quantum-Si Incorporated
QSI Healthcare Medical Devices
Quantum-Si Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.4 million, down 20.3% from fiscal 2024. In the quarter to June 2026, revenue fell 41.8%, EPS grew 31.3% and free cash flow grew 9.75%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.12
0.19
−14.50%
Follow QSI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | 2 | 2 | 3 |
| (52.44%) | (46.52%) | (46.38%) | (49.11%) | ||
| (47.06%) | (41.07%) | (42.85%) | (43.98%) | ||
ROIC |
(843.28%) | (126.60%) | (97.95%) | (100.92%) | |
Return on Tangible Assets |
(50.98%) | (61.04%) | (76.18%) | (83.46%) | |
Average Days of Receivables |
619.59 | 779.00 | 40.01 | 12.96 | |
Free Cash Flow per Share |
(0.50) | (0.49) | (0.44) | (0.43) | |
Free Cash Flow |
(105.22) | (97.23) | (95.69) | (93.69) | |
Capital Expenditures |
(3.97) | (2.52) | (1.49) | (1.24) | |
| Other line items | |||||
Cash ROIC |
(22.82%) | (25.38%) | (29.17%) | (32.09%) | |
Accounts Receivable Turnover |
0.99 | 0.75 | 3.00 | 0.57 | |
Accounts Payable Turnover |
0.88 | 0.72 | 0.60 | 0.55 | |
Inventory Turnover |
0.40 | 0.35 | 0.34 | 0.35 | |
Average Days of Payables |
319.85 | 461.73 | 588.07 | 556.77 | |
Days of Inventory on Hand |
834.79 | 909.51 | 719.82 | 709.35 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,882.31% | 2,206.86% | 2,944.33% | 3,435.51% | |
Selling, General and Administrative Expense of Revenue |
1,535.51% | 1,837.19% | 2,295.52% | 2,529.22% | |
Share Based Compensation of Revenue |
330.19% | 442.24% | 592.66% | 693.46% | |
Operating CF/Net income |
0.87 | 0.93 | 0.91 | 0.94 | |
Depreciation/Fixed assets |
(0.30) | (0.27) | (0.17) | (0.05) | |
Capex/Depreciation |
0.97 | 0.71 | 0.74 | 2.18 | |
Revenue per Share |
0.02 | 0.01 | 0.01 | 0.01 | |
Operating CF per Share |
(0.48) | (0.48) | (0.44) | (0.42) | |
Capex per Share |
(0.02) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
1.25 | 1.03 | 0.80 | 0.77 |
Columns are period end dates